BioCentury
ARTICLE | Finance

Protean charm

Why new investors pile into Proteus for digital medication monitoring

June 9, 2014 7:00 AM UTC

Rather than testing the IPO market, Proteus Digital Health Inc. opted for more private money to further develop its digital health management system, which monitors adherence and responses to oral medications.

Undisclosed private institutional investors contributed to last week's $120 million series G round, which brought Proteus' total fundraising to over $300 million...